Fulgent Genetics (FLGT) Operating Leases (2019 - 2025)
Fulgent Genetics (FLGT) has disclosed Operating Leases for 6 consecutive years, with $3.8 million as the latest value for Q4 2025.
- Quarterly Operating Leases fell 8.23% to $3.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.8 million through Dec 2025, down 8.23% year-over-year, with the annual reading at $3.8 million for FY2025, 8.23% down from the prior year.
- Operating Leases hit $3.8 million in Q4 2025 for Fulgent Genetics, up from $3.6 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $8.8 million in Q4 2022 to a low of $3.6 million in Q3 2025.
- Historically, Operating Leases has averaged $5.4 million across 4 years, with a median of $4.4 million in 2024.
- Biggest YoY gain for Operating Leases was 8.23% in 2025; the steepest drop was 47.38% in 2025.
- Year by year, Operating Leases stood at $8.8 million in 2022, then fell by 18.74% to $7.1 million in 2023, then plummeted by 42.35% to $4.1 million in 2024, then dropped by 8.23% to $3.8 million in 2025.
- Business Quant data shows Operating Leases for FLGT at $3.8 million in Q4 2025, $3.6 million in Q3 2025, and $3.8 million in Q2 2025.